Pharma Circle Panel
Emel Adaligil
Senior Scientific Manager, Genentech
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 45 years.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
We celebrate our unique history as the pioneers of scientific breakthroughs that have an incredible track record of improving lives. And yet, our ambitions are bigger and bolder. Together, we are united in a bold quest to solve the world’s most complex health challenges and serve society.
Our ability to bring transformative medicines to patients depends on the positive experience, engagement and resilience of everyone who works here. Our employees are the heart of Genentech and the driving force behind the progress that brings important new medicines to the people who need them. We believe a great people experience is critical for revolutionizing healthcare and that’s why we’re committed to cultivating an environment where people feel valued, included and able to thrive.
Professional Positions
2021 -present Senior Scientific Manager,
Macrocycle Discovery and mRNA Display Platform Lead
Peptide Therapeutics Department, Genentech
Education
2017-2021 Postdoctoral Fellow,
Early Discovery Biochemistry Department, Genentech
2017-2017 Postdoctoral Fellow,
Department of Cancer Biology, Dana-Faber Cancer Institute
Department of Biological and Biomedical Sciences, Harvard Medical School
2010-2016 PhD in Chemistry,
Department of Chemistry, Tufts University (Prof. Krishna Kumar Lab)